These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri. Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002 [TBL] [Abstract][Full Text] [Related]
9. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007 [TBL] [Abstract][Full Text] [Related]
10. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Imtiaz U; Manavathu EK; Mobashery S; Lerner SA Antimicrob Agents Chemother; 1994 May; 38(5):1134-9. PubMed ID: 8067751 [TBL] [Abstract][Full Text] [Related]
11. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis. Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143 [TBL] [Abstract][Full Text] [Related]
12. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Ishii Y; Ohno A; Taguchi H; Imajo S; Ishiguro M; Matsuzawa H Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581 [TBL] [Abstract][Full Text] [Related]
13. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain. Thomson CJ; Amyes SG FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862 [TBL] [Abstract][Full Text] [Related]
14. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital. Chouchani C; Ben-Achour N; M'charek A; Belhadj O C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis. Corkill JE; Hart CA; McLennan AG; Aspinall S J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952 [TBL] [Abstract][Full Text] [Related]
16. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Bradford PA; Cherubin CE; Idemyor V; Rasmussen BA; Bush K Antimicrob Agents Chemother; 1994 Apr; 38(4):761-6. PubMed ID: 8031043 [TBL] [Abstract][Full Text] [Related]
17. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes. Poirel L; Mammeri H; Nordmann P Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821 [TBL] [Abstract][Full Text] [Related]
18. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178 [TBL] [Abstract][Full Text] [Related]
19. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors. Kitzis MD; Billot-Klein D; Goldstein FW; Williamson R; Tran Van Nhieu G; Carlet J; Acar JF; Gutmann L Antimicrob Agents Chemother; 1988 Jan; 32(1):9-14. PubMed ID: 2831817 [TBL] [Abstract][Full Text] [Related]
20. Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamases. Payne DJ; Amyes SG J Med Microbiol; 1993 Feb; 38(2):114-7. PubMed ID: 8429536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]